Baseline and Follow-up Characteristics of Study Patients
| Studied variables | N = 28 |
|---|---|
| Baseline characteristics | |
| Quantitative variables | |
| Age (yr) | 45 ± 8.8 |
| EDSS | 4.5 (3-6) |
| Time of MS evolution (yr) | 12 ±7.7 |
| Time of follow-up consultation (day) | 124 ± 144 |
| Categorical variables | |
| Sex (female) | 22 (78.6) |
| MS-RR | 10 (35.7) |
| MS-P | 8 (28.6) |
| Fecal incontinence | 6 (21.4) |
| Constipation | 25 (89.2) |
| Fecal urgency | 8 (28.6) |
| Stress urinary incontinence | 4 (14.3) |
| Bladder overactivity | 21 (75.0) |
| Voiding dysfunction | 17 (60.7) |
| Detrusor overactivity | 14 (56.0) |
| Detrusor sphincter dyssynergia | 17 (60.7) |
| Urinary leakage | 13 (46.4) |
| Laxative | 22 (78.6) |
| Rectal suppository | 17 (60.7) |
| Digital extraction | 11 (39.3) |
| Follow-up characteristics | |
| Follow-up time (day) | 124 ± 144 |
| Continuing TAI | 21 (75.0) |
| TAI used 2-times a week | 11 (39.0) |
| TAI used 1 or 3 times a week | 4 (14.3) |
EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; MS-RR, multiple sclerosis–relapsing remitting; MS-P, multiple sclerosis–progressive; TAI, transanal irrigation.
Values are presented as mean ± SD, median (interquartile range [first quartile-third quartile]), or n (%).